Cargando…
13-cis-retinoic acid inhibits the self-renewal, migration, invasion and adhesion of cholangiocarcinoma cells
13-cis-retinoic acid (13CRA), a Food and Drug Administration-approved drug for severe acne, is currently being investigated for its potential use in skin cancer prevention. 13CRA has been reported to exhibit antitumor effects against various types of cancer cells, both in vitro and in vivo. However,...
Autores principales: | Butsri, Siriwoot, Kukongviriyapan, Veerapol, Senggunprai, Laddawan, Kongpetch, Sarinya, Prawan, Auemduan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911079/ https://www.ncbi.nlm.nih.gov/pubmed/36660943 http://dx.doi.org/10.3892/ijmm.2023.5223 |
Ejemplares similares
-
All-trans-retinoic acid induces RARB-dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells
por: Butsri, Siriwoot, et al.
Publicado: (2022) -
Licochalcone A Induces Cholangiocarcinoma Cell Death Via Suppression of Nrf2 and NF-κB Signaling Pathways
por: Laphanuwat, Phatthamon, et al.
Publicado: (2022) -
Crucial Role of Heme Oxygenase-1 on the Sensitivity of Cholangiocarcinoma Cells to Chemotherapeutic Agents
por: Kongpetch, Sarinya, et al.
Publicado: (2012) -
Anti-metastatic Potential of Natural Triterpenoid Cucurbitacin B Against Cholangiocarcinoma Cells by Targeting Src Protein
por: Kaewmeesri, Putthaporn, et al.
Publicado: (2022) -
Inhibition of growth and migration of cholangiocarcinoma cells by pamidronate
por: Buranrat, Benjaporn, et al.
Publicado: (2019)